Global Neurology Academy

Continuum of Care: Managing DMD in Pediatric and Adult Patients
Continuum of Care: Managing DMD in Pediatric and Adult Patients
NeuroFrontiers
Continuum of Care: Managing DMD in Pediatric and Adult Patients
- John F. Brandsema, MD
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
NeuroFrontiers
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
- Charles Turck, PharmD, BCPS, BCCCP
- John F. Brandsema, MD
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
NeuroFrontiers
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
- Charles Turck, PharmD, BCPS, BCCCP
- Dr. Robert J. Shmookler Reis, PhD
- Dr. Srinivas Ayyadevara, PhD
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
CME/CE
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
1.00 credit
- Michael Erdman, PharmD, BCCCP
- Ali A. Habib, MD
1.00 credit
Optimizing Nutritional Support for Patients with Duchenne Muscular Dystrophy
Optimizing Nutritional Support for Patients with Duchenne Muscular Dystrophy
NeuroFrontiers
Optimizing Nutritional Support for Patients with Duchenne Muscular Dystrophy
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
CME/CE
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
1.00 credit
- Perry Shieh, MD, PhD
1.00 credit
The Silent Struggle: Understanding ADHD's Impact on Girls and Women
The Silent Struggle: Understanding ADHD's Impact on Girls and Women
NeuroFrontiers
The Silent Struggle: Understanding ADHD's Impact on Girls and Women
- Kathleen Nadeau, PhD
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
CME/CE
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
1.00 credit
- Craig M. McDonald, MD
- Crystal Proud, MD
- Aravindhan Veerapandiyan, MD
1.00 credit

Medical News

Medical News
Case Western Reserve Awarded $3.3M NIH Grant to Investigate Brain Proteins in Alzheimer’s Disease
thedaily.case.edu
10/04/2024
Read more
Medical News
Experts Call for Nutrition Education Overhaul in U.S. Medical Schools
hsph.harvard.edu
10/04/2024
Read more
Medical News
New Insights Into How the Brain Combines Pain Expectations and Stimuli
medicalxpress.com
10/01/2024
Read more
Medical News
Falls in Older Adults May Signal Early Dementia Risk
medicalxpress.com
10/01/2024
Read more

See more news

CME/CE

On the Clinic Floor: Addressing the Most Critical Questions of Frontline Clinicians in Multiple Sclerosis Management
On the Clinic Floor: Addressing the Most Critical Questions of Frontline Clinicians in Multiple Sclerosis Management
CME/CE
On the Clinic Floor: Addressing the Most Critical Questions of Frontline Clinicians in Multiple Sclerosis Management
1.00 credit
- Robert Shin, MD, FANA, FAAN
- Enrique Alvarez, MD, PhD
- Jiwon Oh, MD, PhD, FRCPC
1.00 credit
The Multiple Faces of ATTRv-PN
The Multiple Faces of ATTRv-PN
MinuteCE®
The Multiple Faces of ATTRv-PN
1.00 program credit
- Sami Khella, MD
- Marcia Waddington-Cruz, MD, PhD
1.00 program credit
ATTRv-PN: A Complicated Disease With a Poor Prognosis
ATTRv-PN: A Complicated Disease With a Poor Prognosis
MinuteCE®
ATTRv-PN: A Complicated Disease With a Poor Prognosis
1.00 program credit
- John Berk, MD
- Sami Khella, MD
1.00 program credit
ATTR Amyloidosis: Familial Vs Wild-Type
ATTR Amyloidosis: Familial Vs Wild-Type
MinuteCE®
ATTR Amyloidosis: Familial Vs Wild-Type
1.00 program credit
- Noel Dasgupta, MD, FACC
1.00 program credit

Clinical Practice

Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
NeuroFrontiers
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
- John F. Brandsema, MD
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
NeuroFrontiers
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
- Ashley Baker, MSN, PMHNP
- Istvan Mody, PhD
Public Health Disparities in Alzheimer's Disease and Brain Health
Public Health Disparities in Alzheimer's Disease and Brain Health
NeuroFrontiers
Public Health Disparities in Alzheimer's Disease and Brain Health
Addressing ADHD in Women: A Guide to Diagnosis and Treatment
Addressing ADHD in Women: A Guide to Diagnosis and Treatment
NeuroFrontiers
Addressing ADHD in Women: A Guide to Diagnosis and Treatment
- Ashley Baker, MSN, PMHNP
- Kathleen Nadeau, PhD

Programs

Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
NeuroFrontiers
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
- Charles Turck, PharmD, BCPS, BCCCP
- Jasmohan Bajaj, MD
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
NeuroFrontiers
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
- Charles Turck, PharmD, BCPS, BCCCP
- Nadia Merchant, MD
- Melody Shi, MD
- Despoina Galetaki, MD
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
NeuroFrontiers
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
- Sandy Millman
- Pinki Prasad, MD
Understanding ADHD: Epidemiology, Impacts, and Management
Understanding ADHD: Epidemiology, Impacts, and Management
NeuroFrontiers
Understanding ADHD: Epidemiology, Impacts, and Management